Why is Redox Responsive Release Important in Cancer Therapy?
Cancer cells are characterized by a unique redox environment, often displaying elevated levels of reactive oxygen species (ROS) and reduced levels of antioxidants like glutathione (GSH). These differences create an opportunity to design drug delivery systems that specifically respond to the redox conditions in cancer cells, thereby minimizing off-target effects and enhancing therapeutic efficacy.
